Crop spraying in the United States could make a £250 million antifungal drug ineffective before it even reaches the market, ...

Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.

An estimated 6.5 million people develop invasive fungal infections each year, with about 2.5 million deaths directly caused ...

Fungal infections in India pose public health risks, with growing concerns of drug resistance, especially in vulnerable ...

The 'ordinary office worker' from Chongqing in southwestern China sought medical help after developing a severe cough that ...

“Not only is the pipeline of new antifungal drugs and diagnostics insufficient, there is a void in fungal testing in low- and middle-income countries, even in district hospitals. This diagnostic ...

The World Health Organization (WHO) this week published two reports spotlighting gaps in adequate medicines and diagnostic ...

The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for ...

The WHO warns of rising resistance in fungal diseases, posing global health risks. Candida infections are increasingly tough ...

WHO said that fungal diseases, including drug-resistant infections like Candida, are increasingly affecting immunocompromised ...

GPs are failing to spot the symptoms of a drug-resistant 'super-fungus' thought to be spreading throughout the UK, experts ...

The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is described in Nature.The drug, named mandimycin, is a member of a known family ...